Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.475 USD | -1.80% | +0.12% | +0.12% |
May. 14 | Wedbush Adjusts Voyager Therapeutics' PT to $8 From $10, Keeps Neutral Rating | MT |
May. 13 | Transcript : Voyager Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.12% | 469M | |
+30.99% | 50.85B | |
+1.46% | 42.82B | |
+48.77% | 42.03B | |
-4.22% | 29.55B | |
+11.03% | 26.11B | |
-22.28% | 19.13B | |
+7.54% | 13.05B | |
+26.80% | 12.16B | |
+23.30% | 12.08B |
- Stock Market
- Equities
- VYGR Stock
- News Voyager Therapeutics, Inc.
- Voyager Therapeutics Starts $100 Million Common Stock Offering; Shares Slump After Hours